Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Debora Beldì"'
Autor:
Elena Gallizia, Eleonora Ferrara, Debora Beldì, Micol Zannetti, Gianfranco Loi, Pierfrancesco Franco, Alessandra Gennari, Marco Krengli
Publikováno v:
Reports of Practical Oncology and Radiotherapy. 27:778-786
The present study assessed clinical outcomes of stereotactic body radiotherapy (SBRT) in oligometastatic prostate cancer patients.Between 2017 and 2020, 37 lesions (12 osseous and 25 nodal targets) detected with conventional and/or functional imaging
Autor:
Gianluca Gaidano, Marco Krengli, Debora Beldì, Lorenzo De Paoli, Federico Mastroleo, Eleonora Ferrara, Micol Zannetti, Mario Pirisi, Mariangela Greco, Erica Matino
Publikováno v:
Translational Cancer Research
In COVID-19 pandemic, cancer patients may be vulnerable for their immunological status and need of immunosuppressive anti-neoplastic treatments Choosing the best treatment option in COVID-19 positive cancer patients is still a challenging issue We re
Publikováno v:
Bulletin du cancer. 109(7-8)
The present study aims to identify predictive factors for urinary toxicity and self-reported symptoms after external beam radiotherapy (EBRT) for prostate cancer.Two-hundred and eighty patients treated with EBRT for prostate cancer were included in t
Publikováno v:
Practical radiation oncology. 10(6)
We aim to develop and validate a new adaptive method for prostate cancer radiation therapy (RT), using an offline strategy to improve treatment personalization by modeling the internal target volume on individual basis and account for the residual se
Autor:
Sara Tunesi, Corrado Magnani, Marco Krengli, Carlo Terrone, S. Torrente, Debora Beldì, G. Apicella, Alessandro Volpe, Giansilvio Marchioro
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 20(2):113-122
To assess the outcomes of patients treated with postoperative RT in relation to the possible prognostic factors.Postoperative radiotherapy (RT) has been proved to reduce the risk of biochemical recurrence in high-risk prostate cancer patients. Baseli
Autor:
G. Apicella, Marco Krengli, C. Pisani, Debora Beldì, Valentina Amisano, Gianfranco Loi, Marco Brambilla
Publikováno v:
Radiation Oncology (London, England)
Background Image guided radiotherapy (IGRT) is an essential pre-requisite for delivering high precision radiotherapy. We compared daily variation detected by two non-ionizing imaging modalities (surface imaging and trans-abdominal ultrasound, US) to
Autor:
Debora Beldì, Marco Brambilla, Marco Krengli, Silvia Crespi, G. Apicella, S. Torrente, Gianfranco Loi
Surface-based image guided radiotherapy (IGRT) allows positioning and/or monitoring patients in 3 dimensions (3D), without the use of ionizing radiation. In this study, we report on intra-fraction motion measured by acquisition of multiple images of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7211111bd0795516c3d430de5fc2e656
https://hdl.handle.net/11577/3465823
https://hdl.handle.net/11577/3465823
Autor:
Debora Beldì, Rita Fossaceca, Laura Masini, Raffaella Quarta, Sara Zizzari, Alessandro Stecco, Marco Brambilla, C. Pisani, Alessandro Carriero, Marco Krengli
Publikováno v:
Journal of Neuro-Oncology. 102:261-271
To analyse the role of MR diffusion-tensor imaging (DTI) and perfusion-weighted imaging (PWI) in characterising tumour boundaries in patients with glioblastoma multiforme. Seventeen patients with surgically treated WHO IV grade gliomas who were candi
Autor:
Maurizio Di Salvo, Marco Krengli, Gianfranco Loi, A. Ballarè, Debora Beldì, Gianmarco Ferrari
Publikováno v:
Università degli Studi del Piemonte Orientale-IRIS
Aims and background Rectal and urinary toxicities are the principal limiting factors in delivering a high target dose to patients affected by prostate cancer. The verification of such toxicity is an important step before starting a dose-escalation pr
Autor:
Sara Rubinelli, Carlo Terrone, Cristina Bozzola, Oscar Alabiso, Debora Beldì, Francesca D'Avanzo, Romeo Palma, Loredana Pagano, Florian Stratica, Alessandra Mosca, Alessandro Volpe
Publikováno v:
Acta Medica International. 3:158
Exposure to androgen deprivation therapy (ADT) by prostate cancer (PCa) patients is increasing, either in early-stage and in metastatic disease. Frequently, ADT becomes a long-term treatment, lasting even more than 10 years, starting with gonadotropi